Knightscope Revenue Up 2%, Net Loss Up 126% In 2021

By John Honovich, Published Apr 01, 2022, 08:49am EDT (Research)

*********** ******* *** ** **** *% year **** **** ** **** ***** its *** **** **** **** *******.

IPVM Image

*** ******* ********** **** *******, ******* **** **** doubling ** ***** *** **** ******** 75% **** *** ****.

****** **** ****, ** ******* *** company's ****-**** **** ******* *** *** the **** ******* *** ************ **** an **** ******* **** ** *** company's ***** *** *** ********* ** an ******* ********.

Financial ********

***********'* **** ********* ******* *** * number ** ********, ********* ********* *** **** **-*:

IPVM Image

******** *******:

  • ******* *** ****** ** *%, ****** Knightscope ********* ** ** "********** ****".
  • ***** ***** ******* **** ******* ********.
  • **** ***** ****** ** ** ***** and ********* ** **** ******* ** from *******.
  • ***** **** **** ********** *** ~** its *******.
  • ******** ******** ($*.* *******) **** ************* greater **** *******.

Client ************

*** ******* ****** "****** ***** ****** and ****** ************ ************" *** *** "relatively ****" *******.

*** **-* *** ** ****** ** count *** "********-**-*******" ****** ******** ******* listed *** ***** ****** ** ******** / ****** **** *********** *** ** production, ***** *** ~**.

** ********* *** ********* ***** ** indicating *** ***** ****** ****** ******** or ************* ******* *** ****** ** robots **** *** *****:

*** *** **** ***** ******** **, 2021, *** ******* *** *** ******* who ************ ********* *** **% ** more ** *** *******’* ***** ****** revenue (**% *** **%) ******** **** three ******* *** *** **** ***** December **, **** (**%, **% *** 10%).

***** ******* *** *********** *** **** year **** ****, *** ******* ************* to ********, ******* * ******** ******** or ******** ***** ***** ** ***********'* robots.

*** ******* **** **** "********-******* ********* hardship" ** * ******:

***** ******** ****** ********* *** ** pandemic-related ********* ******** *** *** ** effect ** *** *******’* *******, **** deployments *** ******** ********* **** **** delayed ****** *** ** ********* ** access *** ********** ****** *** ******** and *******-**-***** ******.

Supply ***** ******

*********** **** ****** ****** ***** ******:

*** ******* *** *********** ****** ***** constraints ********* **** *** *****-** ********, which *** ****** **** ********** *** will ********** ****** *** ****** ** deploying **** ** *** *******. ** addition, ** *** **** ************ ****** chain ****** ** * ****** ** the ****** ** *** ********** ******** in *** *******. ***** ****** *********** include, *** *** *** ******* **, semiconductor ********* ** **** ** ********* of ******* ***********.

************, ********* **** ******* *** ***** (Knightscope **** *** ~** ****** ** service) *** **** *** **** ****** (Knightscope ******* ~$**,*** *** ****) ****** have **** ****** **** ********* ********* since **** ** *** **** **** many ********** *** *** *** * premium *** *** *** **** ****.

No ****** *** ****** *******

*** '********** ****' ******* ***** ** existential ****** *** *** *******. ***** are **** ***** **** *****-***** ********** companies *** **** (****** *********** ** now * ***** ***) **** *** be ******** (**** ***** *******, **** cost ** *****, ***.) *** ** the ******* ****** **** ******* *************, there ** ****** **** ** ******** the ***** **** ********* ****.

Ability ** **** ********

***** *********** *** ****** **** *** sell ****** ** ********* (**** **** an *********** ******* ** $***+ ******* versus $*.* ******* ** *******), **** continue ** **** **** ******** **** selling ****** ******** ** ****** *********.

** *** **** *** ******, *** company *** ********* * ****** ** small **** *** ** ******* ******* if **** ** ********** ******* ******* or ********* ******* *** *****.

No ****** ***********

*********** ******* ** ****** *********** *** premises ** ** *** ************* ** selling **** ******* *** ****** ******:

** *** ******, ** *** *** aware ** *** ****** *********** ** the ******** ******** ******** ********** ***** that **** ****** ********** ******** ** the ****** ******,outdoors *** *******, at the same scale as Knightscope with actual paying clients.

**** ** *** *********** ********* **:

** *** ***** ** * *****-**, SMP ******** ******** ****. (“***”), ***** produces ** ******* ********** ******** ******** that ** ******* ******* *****-***** ************ and ** *** ********* ******* ** international *******. ** *** ********** ****** Gamma * ******** *** ***** *********** as ********* *********** ** **** *****. However, ********* ** ******** *******, ** understand **** **** ***** * ******** and ***** *********** **** ****** ********** in *** ******** ***** ***** ***** failed ******** ** ***** *** ******, and *** **** ****** ******* **** its ***** ******** ***********. ****** ********, a *****-** *********** ******* ** ****** applications, *** ** ********** * ******* competitor, ******** *** ******** *** *** fully ********** *** **** ** * telepresence ******** ***** ********. ************, ****** AI *** ******** ***** ******** ** indoor-only ***** *** ******* ********** ******* has ********* ** **** *** ********** fixed ****** *********, ******* ** ***** fixed *********, **** ** ***** ******* by *******.

*******-************ **** **** **** **** *** more ****** ** ********** * ****** ****** **** **** Knightscope.

********** ** *** **** ** ******** of ***********, ***********'* **** *********** ********* is *** ******* *******.

Super ****** / ******** *******

*** **-* **** ***** **** * Co-Founders ** *** ******* **** **.*% of *** *******'* ***** ****** ****** making **** *********** ** *******:

** ** ******** **, ****, *** holders ** *** ***** ****** ***** beneficially **** ************* **.*% ** *** Company’s ***** ****** ******, **** **. Li *** **. ******** ************ ******* approximately **.*% *** **.*%, ************, ** the *******’* ****** ******. ** * result, ******* ** *** ***** ****** Stock (********* ******* ******** ** *** Company) **** ** **** **exert * *********** ****** ** ********* over our management and affairs and control **** ******* requiring stockholder approval, including the election of our directors and approval of significant corporate transactions.

Cash **** *** ** ***** *** ****

** *** ******** **** *** *** company, ** ** * ***** ***, the ******* *** $**+ ******* ** cash ** **** *** *********** **** lasting ** ***** * ****:

** ** ***** **, ****, *** Company’s **** ******* *** ************* $**.* million, ***** ******** *** ******** **** the ********** * ******** ********** ** January **, **** ** ********* ** Note ** – ********** ******. *** Company *** ********* ********* ****** *** negative **** ***** ** ************* $*.* million *** *****, ** *******, *** the **** ******* ******. *** ******* has ********** ******* ******* ** **** at ***** ****** ****** ** **********.

Critical ****

*** *-**** *** *** ********-****** ******* with "********** ****" ******* ***** * crucial ****. ** *** *** ****, given *** **** **** **** **** raising ***** **** ********* ******* **** low *******, **** *** **** **** be **** ** ***** **** *****. But *** **** *** ******* *** go **** ******* ** *** ** a ********.

Comments (6)

* ** *** *** *** *********** manages ** *******. *** **** *** going ** ** ********* ********** ** raise **** ******* *** ***** **** the ******** ******* *** ****** ** gain *** ******** * ** *** see **** ***** ****** *** *******/*****.

*** **** ******** *** ****** **** anyone *** ***** ** ********* *** part ** *** *******.

Agree
Disagree
Informative
Unhelpful
Funny

**** ***, **** *** ***********, **** published * ***** ******* **********"$*** ******* *. ***** ********* ****** Facility". ** **, **** ***:

******* ******* **** ** ********* ** a ******* ****** ** **** *-* to ** ***** ** *********** **** the ********** *** ******** **********.

*******, * *** *****,***** ** ** *** *** ******. ****,* ******* ***.***, *** ** *** Knightscope ****** ***** ****.

** *** ***** *******, *********** ****:

*** ********* ****** ******** ******** *********** with *** *****, ******* **********, ** sell *** ***** ** ** $*** million ** *** ***** * ****** Stock **** * ****** ** ** months ** *. ***** ** ***********’* discretion, ******* ** ******* *********** *** conditions

**** ************* ****** ******* *** *********** but ***** *** ** ******* ** what ***** ** ***** *********** ***** do **** **.

**** *****, ***** *** ************, *********** stock ****** *** ** ***** ** was **** ****.

IPVM Image

Agree
Disagree
Informative
Unhelpful
Funny

*'* *** **** ** ** **** worth ****** ** ****** **** *** at **** *****. *** **'* **** a ***** **** *** *** *** to ***** **** ****, ** *** they *** **** ***** ** *** to ************* ** **** **********.

Agree: 1
Disagree
Informative
Unhelpful
Funny

*** *** ****** *** *** $*** million *. ***** ********* ** *** out.

******* ********, *. ***** **** **** at *** ******* ****** *****:

*** *** ***** ******** ***** *** the ****** ** ***** * ****** Stock **** *** ******* ****** ** sell ** *. ***** ********* ******* in ** ******** ******** ******** ** the ******** *********, ** ***, **** be ********** ** *** **** ****** as ** *** **** ** * regular ********, ******** **** *** **** for **** ******** ******** **** ** measured ****** *** ******* ** *** normal ******* ***** ** ****** ** the ********** ******** **** **** **** begin ** ******* ***** *** ****** of (*) *** **** **** *** applicable ******** ******** ****** ** ****** received ** *. ***** ********* *******, (ii) *** **** **** *** ******** Valuation ****** *** *** ***** ******* Purchase ******** ** *** **** ******** Date (** ***) *** ***** *** (iii) *** **** **** *** ******** Purchase ********* ****** (******* *****) *** the **** ****** ***** ******** ******** effected ** *** **** ******** **** (if ***) *** *****, *** ****** at *** ******* ** (*) *** official ***** ** *** ******* ******* session ** ****** ** **** ******** Date *** (*) *** **** *** volume ** ****** ** ***** * Common ***** ****** ** ****** ******* a ******* ********* ****** ********** ** accordance **** *** ******** ********* (**** period *** **** ******** ********, *** ******** ******** ********* ******”), **** * ***** *.*% ******** to *** **** *** **** ******** Purchase ********* ******.

*. ***** ** ***** **** ** Knightscope ** ***** ****** *********** ******, which ** *** ******* ~$* ****** price, **** ** **** ******* ******* to ** *** ********* *** ******* half ******* ***** *. ***** ***** $50 ******* ** *****:

** ************* *** *. ***** ********* Capital’s ********** ** ******** ****** ** Class * ****** ***** ** *** Company’s ********* **** *** ***** *** subject ** *** ********** *** ***** in *** ******** *********, **** ********* of *** ******** *********, *** ******* issued **,*** ****** ** ***** * Common ***** ** *. ***** ********* Capital ** ******* ********** ******. ** addition, (*) **** *** *******’* ******* of ***** ********* ***** **** ******** equal ** $**,***,*** ** ******* ** B. ***** ********* ******* *** *** shares ** ***** * ****** ***** purchased ** *** ********* *** ******** Purchases (** **********) ******** ** *** Company ******** ** *** ******** *********, the ******* **** ***** **,*** ********** shares ** ***** * ****** ***** to *. ***** ********* ******* ** additional ********** ******, *** (**) **** the *******’* ******* ** ***** ********* gross **** ******** ***** ** $**,***,*** from *. ***** ********* ******* ***** the ******** *********, *** ******* **** issue ** ********** **,*** ****** ** Class * ****** ***** ** *. Riley ********* ******* ** ********** ********** shares, ******** **,*** ********** ********** ****** (in ******** ** *** **,*** ******* commitment ****** *** ******* ****** ** B. ***** ********* ******* **** ********* of *** ******** *********).

*** ******* **** ** ******* **** shares ** ******* ******** ******** ** the ***** ***** ** ****** *** grow ****** **** ****** *** *** stock.

*** ** *********** *** *** **** to **** **** ** ******** ** dollars ** **** ***** **** ***** give **** * ************* ******* ******.

Agree
Disagree
Informative
Unhelpful
Funny

*********** *** *** ***** * **** D**** *** *** ********** **** *** selling $*** ******* ** *** ******:

IPVM Image

Agree
Disagree
Informative: 1
Unhelpful
Funny: 1

***** *'** *** **** ********/**** *****, I'm ********* ** ** *** **** of ******** ** *** ** ******* now.

Agree
Disagree
Informative
Unhelpful
Funny: 1
Subscribe to IPVM Research to read the full report.
Why do I need to subscribe?
The IPVM Research Service includes products tests and shootouts plus competitive and financial analysis, helping decision-makers better evaluate purchasing, partnering, developing, and/or competing against companies in physical security.
Already have an account?
Loading Related Reports